T issue-resident leukocytes can be categorized by their cellular origin and means of maintenance as either self-renewing cells that seed nonlymphoid organs during ontogeny or cells that are replenished hematogenously from precursors in the bone marrow (BM) or secondary lymphoid organs (SLOs), such as the spleen and lymph nodes (LNs). Innate lymphoid cells (ILCs) have been identified in embryonic tissues, BM, SLOs, peripheral blood, and many nonlymphoid tissues, including mucosal sites such as the lung and small intestine, where they contribute to tissue immunosurveillance, immunoregulation, repair, and homeostasis (1, 2) . How ILC populations in lymphoid and nonlymphoid organs are maintained, and whether ILCs recirculate from lymphoid to nonlymphoid tissues, have been controversial questions. Based on the identification of fetal ILC progenitors that seed the mouse intestine (3) and the proposed development of ILCs in human tonsils (4), it is reasonable to expect that ILCs may self-renew locally or be generated from immature precursors in these tissues. However, recent studies have identified progenitors to all currently known ILC subsets in adult BM, raising the possibility that ILCs in lymphoid and nonlymphoid organs are continuously replenished through medullary lymphopoiesis and subsequent recruitment to peripheral tissues (5, 6) .
To directly test whether hematogenous precursors continuously replenish the pool of peripheral tissue ILCs in adult mice, we generated parabiotic mice, which establish blood chimerism through joint circulation (7, 8 fig. S3 ). Because cells isolated from enzymatically dissociated lung tissue include cells from both the vasculature and the parenchyma (10), we injected parabiotic mice intravenously with fluorescently labeled antibody to CD45 5 min before mice were euthanized, in order to identify intravascular leukocytes. This revealed that virtually all ILC2s, but only~20% of Eomes − NK1.1 + ILC1s, localized to the lung parenchyma (Fig. 1, D and E, and fig. S3 ). In contrast to intravascular ILC1s, which derived evenly from both parabionts (Fig. 1E and fig. S3 small intestine, salivary gland, and liver were also overwhelmingly of host origin. Together, these experiments identified all analyzed ILC types as tissue-resident cells in all examined nonlymphoid organs.
Next, we explored whether the long-term maintenance of tissue-resident ILCs was accomplished through self-renewal or through progressive replacement by hematogenous precursors. We analyzed mice that had been in parabiosis for >3 months and found that all analyzed ILC subsets remained >95% host-derived in all nonlymphoid organs tested (Fig. 1, F to I, and fig. S4 ). In contrast, conventional natural killer (NK) and T lymphocytes, which appeared relatively tissueresident in the small intestine in our analysis at day 30 to 40 of parabiosis, had equilibrated with donor-derived cells at 3 months (Fig. 1, F and G). However, over time, we did detect a minor increase from <2 to~5% donor-derived cells for ILC2s in the small intestine and ILC1s in the salivary gland, which we did not observe for the other ILC subsets (fig. S4) . Therefore, although our data are consistent with a minor contribution of hematogenous precursors (5, 6) or circulating mature ILCs (11) to the physiologic renewal of ILC subsets, the majority of ILCs appear to be tissue-resident cells that are locally maintained in peripheral organs. This is in contrast to, for example, the progressive replacement of tissue-resident embryonic macrophages in some adult tissues, such as the intestine, which experience constant immune stimulation and tissue renewal (12) .
Our observation of tissue-resident ILCs in nonlymphoid tissues raised the question of whether ILCs in SLOs are replenished from hematogenous sources or whether they also are locally renewing cells. Unexpectedly, our analysis of mesenteric LNs and spleens of parabiotic mice showed that all ILC subsets tested were >95% host-derived at both 1 and 3 months (Fig. 1, J and K, and fig. S5 ), demonstrating that ILCs establish tissue residency in both lymphoid and nonlymphoid organs.
Although ILCs that leave peripheral tissues via afferent lymphatics can contribute to ILC populations in draining LNs (13) , the identification of tissue-resident ILCs in the spleen, which does not recruit cells via afferent lymphatics, further supports the idea of ILC residency in SLOs. The regional maintenance of ILCs in SLOs thus distinguishes helper-like ILCs from developmentally related NK cells ("killer" ILCs), which, like ab T cells, are continuously replaced by BMderived precursors and recirculate systemically and through SLOs. Nevertheless, Eomes + conventional NK cells can also establish tissue residency in some organs-e.g., the salivary gland and small intestine (Fig. 1) (9, 14) .
To test whether the tissue residency of ILCs is maintained under inflammatory conditions, we generated parabiotic Foxp3 DTR mice. In these mice, and donor-derived (B and D) ILC2s were analyzed in the lung, small intestine lamina propria, and mesenteric LN on days 7 and 15 after infection. (E) Analysis of ILC2s and ILC3s in the small intestine lamina propria on day 15 after infection. In the bar graphs, each symbol represents an individual parabiont. The data are shown as mean T SD and represent two or three independent experiments (n = 6 to 12 parabionts; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant).
the depletion of T reg cells initiates a systemic lymphoproliferative syndrome and fatal autoimmunity (15, 16) . Unexpectedly, we failed to detect an increased contribution of hematogenous cells to the expanded ILC populations in the analyzed organs of parabiotic mice depleted of T reg cells (Fig. 2 and fig. S6 ). This suggests that the mobilization of ILCs or ILC precursors into peripheral tissues is negligible even during systemic autoimmunity, and that the associated increase in ILC populations in lymphoid and nonlymphoid organs probably results from local expansion, despite the influx of hematogenously derived myeloid cells and adaptive lymphocytes (15, 16) . Next, we examined whether local ILC expansion is observed during infection with a helminth, Nippostrongylus brasiliensis (Nb) (17) , that induces strong proliferation and activation of ILC2s in the lung and small intestine. Recent work suggests that Nb infection triggers the appearance of "inflammatory" ILC2s that differentiate further to "natural" ILC2s to sustain the expansion of ILC2s necessary for worm expulsion (18) . To determine whether the ILC response in this setting is due to the mobilization of inflammatory ILCs from the BM or elsewhere, or to local differentiation and expansion, we infected parabiotic mice with Nb and analyzed ILC2s during the acute phase of helminth infection (day 7 after infection). At this time point, ILC2s in the lung, small intestine, and mesenteric LN remained host-derived, despite their robust proliferation and expansion (Fig. 3, A to   D) . In contrast, we observed a small but statistically significant increase in donor-derived ILC2s during the chronic inflammation phase on day 15 after infection (Fig. 3, C and D) (19, 20) . At this time point, ILC2s continued to exhibit increased proliferation (Fig. 3C ) and have been shown to serve critical functions in tissue repair (21) . Thus, the local expansion of resident ILCs during the acute phase of Nb infection is followed by moderately increased hematogenous recruitment or redistribution of ILCs during the chronic inflammation and repair phase. The increase in donorderived cells was specific to ILC2s among innate immune cell types; we could not detect any increase in donor-derived ILC3s or tissue-resident alveolar macrophages (Fig. 3E and fig. S7 ). However, even at this later stage, >90% of ILC2s originated from the host parabiont.
The local proliferation of tissue-resident ILCs led us to ask whether these cells can access the cytokine interleukin (IL)-2, whose availability in lymphoid organs is controlled by T reg cells (22) but whose physiological relevance to ILC responses in nonlymphoid tissues has been controversial. For this purpose, we generated mixed bone marrow chimeras harboring both wild-type ILCs and ILCs deficient in CD25, the high-affinity a-chain of the IL-2 receptor (Fig. 4A) , as previously described (23) . We found that CD25-sufficient (wild-type) and CD25-deficient ILC2s proliferated to a similar extent and were found at equal ratios in Nb-infected and mock-infected chimeric mice, indicating that IL-2 did not directly influence the proliferation of ILC2s in response to Nb infection (Fig. 4, B and C) . However, we observed that CD25-sufficient ILC2s produced more IL-13 (Fig. 4D) , which is required for worm expulsion. These results demonstrate that ILC2s can indeed access physiological levels of IL-2 in nonlymphoid organs, supporting the notion that one function of locally produced IL-2 may be to modulate ILC effector function (22, 24, 25) . We previously suggested competition for IL-2 as one mechanism by which Foxp3 + T reg cells could restrain the homeostasis of splenic ILC1s (23) . It remained unclear in that study whether T reg cells are able to restrain IL-2-dependent ILC activation in nonlymphoid tissues, where they form co-clusters with ILC2s (26). We found that transient depletion of T reg cells induced the IL-2-and CD25-dependent proliferation of ILC2s (Fig.  4 , E to G), suggesting that ILC2s can directly access IL-2 in the lung and the small intestine and that T reg cells restrain the IL-2-dependent expansion of these tissue-resident ILCs.
Our experiments identified ILCs in both lymphoid and nonlymphoid organs as tissue-resident cells that are locally renewed and expanded in response to acute environmental challenges. These findings also suggest that the plasticity of ILCs-exemplified by the differentiation of "inflammatory" to "natural" ILC2s (18), the differentiation of ILC3s to RORgt ILCs can be replenished and complemented, albeit only in part, through contributions of hematogenously derived precursors or mature cells in situations of extended inflammation and tissue repair. Consistent with our findings, it has been reported that ILC subsets are elevated in the peripheral blood of patients suffering from psoriasis (30, 31) . Furthermore, peripheral blood ILC2s have been shown to dynamically modulate the expression of molecules that regulate tissue homing in mice and humans (20, 32) . In addition, we have detected donor-derived lymphoid and ILC progenitors in parabiotic BM ( fig. S8) + in humans) in the early growth and metastasis of tumors. PMo are involved in the resolution of inflammation; they actively survey the endothelium of the vasculature, where they scavenge microparticles and remove cellular debris (7) (8) (9) . The orphan nuclear receptor Nr4a1 (also known as Nur77/TR3/NGIFB) is highly expressed in PMo compared with other immune cells and functions as a master regulator for the development of PMo in mice (10) .
To investigate the actions of PMo during early tumor metastasis, we used mice expressing green fluorescent protein (GFP) under the control of the Nr4a1 promoter (Nr4a1-GFP mice). In these mice, PMo (but not Ly6C + classical monocytes) express high levels of GFP (GFP high ) (10, 11) . We focused our studies on the lung, which is a common site of tumor metastasis and an important locus of PMo activity (12) (13) (14) . We used flow cytometry to confirm that Nr4a1-GFP high cells in the lung were PMo ( fig. S1 , A to C). Tracking of Nr4a1-GFP high cells by confocal imaging in the lungs allowed us to identify a large number of Nr4a1-GFP high PMo patrolling the microvasculature (movie S1 and Fig. 1A) . Consistent with an important role for PMo in the lung vasculature, we found a three-to fourfold enrichment of Nr4a1-GFP high PMo in the lung compared with other tissues (fig. S1D) .
To examine the interactions of PMo with tumors in vivo, we imaged Nr4a1-GFP high PMo in the lung after intravenous (IV) injection of Lewis
